Musli Thyropeutics Ltd.   Report issue

For profit Phase 2
Founded: Zur-Moshe Israel (2014)
Status: Left NME R&D (2021)

Organization Overview

First Clinical Trial
2016
NCT02654041
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now